rentschlerbuildingjpg

Rentschler Biopharma invests in German, US sites as company makes strategic shift

The global CDMO, in a realignment of its business operations, is withdrawing from the field of cell and gene therapy and increasing its focus on biologics.

Be Sure To Read

novo_holdings_sanfran_0011200px

Novo Holdings confirms intention to double Catalent’s size over five years

While declining to comment on the specific growth strategy, a Novo Holdings spokesperson confirmed a statement provided by its senior partner to Reuters last month.
eurofinscdmo_img0454

Eurofins says CDMO bookings are ‘robust’ for 2025, leverages investments in Canada

The company sees its contract development and manufacturing organization business as poised to benefit from investments in Eurofins CDMO Alphora in Mississauga, Ontario.
lifecore_sign

Lifecore Biomedical more than doubles capacity, targets GLP-1 injectables market and Big Pharma

The CDMO recently added a five-head isolator filler, designed for fill-finish activities, with the potential to generate up to $300 million in revenue annually.
screen_shot_20250205_at_9

Trump’s looming tariffs create uncertainty for Agilent’s $925M buy of Canadian CDMO

In September, Agilent completed its acquisition of Biovectra, a contract development and manufacturing organization. Now, President Trump has threatened Canada with tariffs.
shipcontainersheroimage

Trump pauses tariffs on Canada and Mexico, but China still in the crosshairs — what it means potentially for biopharma

President Trump on Saturday imposed tariffs on imports from Canada, China, and Mexico. On Monday, Trump said he would pause the levies on Canada and Mexico.
agc_seattlebuildingfront

AGC Biologics positions itself as ‘friendly’ CDMO as new CEO plots course for 2025

CEO Alberto Santagostino, who took the helm in November 2024, is looking to differentiate the Seattle-based company from other CDMOs targeting the biopharma industry.

Exclusives

Pharma events calendar

Keep track of in-person industry events.


Articles

The latest content from industry thought leaders.


Editors' (re)View

Weekly takes on things going on in the pharma world.

key_to1

The Key to the Smart Factory

As the life sciences sector evolves with personalized medicine, biologics, and digitalization, manufacturers must innovate, invest in advanced tech, and adopt agile manufacturing...
ai_pharma_manufaturing_banner

The Power of AI in Pharma Manufacturing Today

AI and digital tools are vital in pharmaceutical manufacturing. Shiftconnector's AI platform improves efficiency, ensures compliance, and empowers teams with real-time insights...
dreams1

eBook: 2024 Pharma Innovation Awards

This year’s Pharma Innovation Awards are creating tools that elevate precision and efficiency in every step of the drug manufacturing process.
header1

How does UV compare to carbon for chloramine & chlorine reduction?

While an effective disinfectant, the corrosive properties of chloramines can affect the performance and longevity of water treatment equipment. UV offers both economic and physical...

Difco TC Yeastolate ultra-filtered (TCY UF) in scale-up optimization

Improve titer by 50% or more with Gibco peptones
mt_pharmabiotech1540x800

5 Ways to Enhance Bioprocessing with Digital Sensors

Improve bioreactor performance, accelerate process development from benchtop to production, assess respiratory efficiency with continuous CO2 monitoring, eliminate potential interferenc...

With a focus on CGT manufacturing, BioForge will be operational by 2027.

Pittsburgh’s biotech leap

Building on its manufacturing legacy, Pittsburgh is now headed in a new direction — from steel to science

shutterstock_2079390133

Advancing preclinical research with virtual control groups

The future of non-clinical research may depend on integrating VCGs for a more humane and efficient approach.

Notable 2024 FDA decisions

A look at consequential drug approvals and rejections from this year
Michael Annino/Shutterstock AI

Pharma’s molecular glue garden

With key players entering the ring and many clinical trials underway, the molecular glue garden is bound to bloom soon

Batch process understanding for process validation and quality control

A first-of-its-kind study of isotopic values of paired reactants and products offers a prospective new method of process understanding

shutterstock_2467268685

Process performance qualification pitfalls, and how to avoid them

Adhering to a tried-and-true set of best practices during the PPQ stage can prevent a drug approval from stalling out on the final lap.

Michael Annino | Shutterstock-AI
pm2409_hero854x480_2
Large Molecule

Pharma's coming of age

Pharmacologic approaches to treating aging are edging closer to maturity
Michael Annino/Shutterstock AI
pm2409_hero854x480_2coverstory
Large Molecule

Pharma’s new age of longevity: Closing the gap between healthspan and lifespan

New treatments offer the promise of tackling age-related disease multimorbidity
Michael Annino/Shutterstock AI
pm2409_hero854x480_coverstory
Large Molecule

Pharma’s new age of longevity

Novel therapeutic approaches to aging are creating a healthspan market with staying power

Slideshows

Quality & Risk

[Slideshow] 5 steps to improve your contamination control strategy

A robust contamination control strategy isn't merely a guideline, it's a necessity
Microsoft Teams Image (7)
Home

[Slideshow] Pharma Manufacturing's essential reference guide

Quick answers to all your pharma manufacturing questions
Shutterstock 749369605
Home

[Slideshow] What keeps pharma up at night?

13 pharma scaries….and solutions that offer reprieve